CPS Pulver

Quick links to important sections

CPS Pulver

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of CPS Pulver

Quick Facts about CPS Pulver

Property Description
Active ingredient Sodium Polystyrene Sulfonate (SPS)
Form Powder for Suspension (Pulver)
Pharmacological class Potassium Binder, Cation-Exchange Resin
Common use Management of high potassium levels
Origin Synthetic polymer

What Type of Medicine is CPS Pulver?

CPS Pulver is a synthetic, prescription-only medicinal product whose active ingredient is Sodium Polystyrene Sulfonate (SPS), a compound used to manage electrolyte balance. It is formally classified as a Potassium Binder, belonging to the broader category of Cation-Exchange Resins. This classification denotes the core mechanism of the medication, which facilitates the exchange of positively charged ions in the digestive tract. The active substance is a non-absorbable, synthetic polymer, designed specifically to remain within the gastrointestinal system to perform its function. This characteristic is clinically recognized for minimizing the risk of systemic toxicity associated with absorbed pharmaceutical agents.


What Does CPS Pulver Do in General?

The primary general therapeutic purpose of CPS Pulver is to serve as a high-level tool for the management and control of abnormally high potassium concentrations in the blood, a condition known as Hyperkalemia. The medication achieves this by chemically binding to excess potassium ions present in the large intestine. The main function of the resin is the effective reduction of serum potassium concentration, which is critical for heart function. The binding action effectively removes the potassium from the body as the bound drug is excreted in the stool, thereby working to lower and regulate serum potassium levels. For instance, it may be used in the context of chronic kidney disease where potassium excretion is impaired.


Why is it Called CPS Pulver? (Form and Composition)

The name component "Pulver" refers directly to the medicine's physical form: a fine powder intended for suspension. The composition consists of the Sodium Polystyrene Sulfonate polymer, which is insoluble and therefore necessitates mixing with an aqueous vehicle, such as water or syrup, to create an Oral Suspension or Rectal Suspension. This powder formulation provides flexibility, making the product suitable for administration to different patient groups, including those who may not be able to tolerate large tablet volumes. The form requires preparation at the point of use, contrasting with pre-mixed liquid solutions.

Regulatory References

  1. Hyperkalemia - StatPearls - NCBI Bookshelf

What side effects are possible with CPS Pulver?

Possible Side Effects and Safety Information

The safety profile for CPS Pulver (Sodium Polystyrene Sulfonate) is derived from its function as a non-absorbed resin, with documented adverse effects primarily categorized by the Gastrointestinal System and Metabolism and Nutrition Disorders.

Adverse Reactions and Frequencies

Adverse reactions are classified according to regulatory standards:

  • Common Reactions documented in official labeling include nausea, vomiting, constipation, and gastric irritation.
  • The most significant documented safety risk involves the rare but serious potential for severe gastrointestinal injury, including Intestinal Necrosis (tissue death), Ischemic Colitis, and Gastrointestinal Obstruction.

Metabolic and Electrolyte Safety

As a cation-exchange resin, the medicine's use is associated with systemic changes, classified under Metabolism and Nutrition Disorders. The primary concern is the potential for Hypokalemia (abnormally low potassium), as well as Hypocalcemia, Hypomagnesemia, and Sodium retention. These effects necessitate attention to the patient’s overall electrolyte balance.

Safety Constraints and Special Populations

Official prescribing information defines specific situations where this medicine must not be used, notably in patients with obstructive bowel disease, including post-operative ileus or severe constipation. Caution is also detailed for specific groups, as the risk of serious gastrointestinal events is heightened in premature infants and low birth weight infants. Furthermore, the sodium content requires care when administered to individuals with underlying conditions sensitive to sodium overload, such as severe congestive heart failure.

Overdose and Emergency Response

Overdose with CPS Pulver (Sodium Polystyrene Sulfonate) is officially documented to present primarily as severe electrolyte derangement. The main documented manifestation is critical Hypokalemia, a sharp depletion of potassium, which may be accompanied by Hypocalcemia or Hypomagnesemia. Clinically, this severe imbalance can be evidenced by neurological signs such as confusion, profound muscle weakness, and hyporeflexia, potentially progressing to frank paralysis and apnea. The cardiovascular system may exhibit irregular heartbeat and serious cardiac arrhythmias.

Beyond systemic effects, regulatory documents highlight the physical risks associated with the resin in over-exposure. These serious outcomes include gastrointestinal tract ulceration, intestinal necrosis (which may be fatal), and perforation. In neonates and low birth weight infants, there is a noted, specific risk of digestive hemorrhage and intestinal necrosis.

When overdose is suspected, official guidance mandates that the user seek immediate medical attention. Emergency services must be contacted immediately if symptoms such as seizure, trouble breathing, or collapse occur. Overdose management involves immediate discontinuation of the product, followed by symptomatic and supportive treatment, including the correction of electrolyte disturbances. Frequent serum potassium determinations and ECG monitoring may be required.

Therapeutic Uses of CPS Pulver

What CPS Pulver Treats: Main Uses and Benefits

CPS Pulver (Sodium Polystyrene Sulfonate) is commonly used to help manage hyperkalemia, or high potassium levels in the blood, a condition involving systemic imbalance that may create noticeable physiological strain. This medication is commonly used across conditions characterized by periods of heightened symptoms (elevated serum potassium levels) such as Chronic Kidney Disease, Acute Kidney Injury, or due to certain medications.

The core therapeutic goal is the management of potassium concentration, which supports long-term electrolyte balance. This treatment is relevant for easing the symptoms related to heightened physiological activity (such as potential arrhythmias), which supports the management of severe risks associated with hyperkalemia. Beyond cardiovascular stability, managing the imbalance may assist with symptom clusters that create noticeable physiological strain, such as muscle weakness and fatigue. It is commonly used to help with maintaining a sense of stability and support general well-being during symptomatic phases.


Quick Fact: Support for Stability

Property Description
Relief for Symptoms that interfere with daily functioning (e.g., muscle weakness, fatigue)
Main Indication Hyperkalemia (high potassium)
Core Benefit Contributes to maintaining functional stability
Usage Context Chronic management in kidney function impairment

Regulatory References

  1. NIH StatPearls overview on Sodium Polystyrene Sulfonate

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Calcium Polystyrene Sulfonate (CPS Pulver)

This section summarizes who can and cannot use Calcium Polystyrene Sulfonate, based strictly on official regulatory information.


Populations for whom use is Contraindicated (Must Not Use)

Category Contraindication Statement
Hypersensitivity Patients with a known hypersensitivity to polystyrene sulfonate resins.
Gastrointestinal Patients with obstructive bowel disease.
Metabolic Patients with conditions associated with hypercalcaemia (e.g., hyperparathyroidism, multiple myeloma).
Neonates Neonates with reduced gut motility (post-operatively or drug-induced) and all neonates for oral administration.

Populations for whom use is Not Recommended/Restricted

Category Restriction Statement
Gastrointestinal Use is not recommended in patients with compromised gastrointestinal motility (including immediate post-surgery or drug-induced).
Pregnancy/Lactation Not recommended during pregnancy due to limited data. For lactation, a decision to discontinue the drug or breast-feeding is required.
Pediatric Use Particular care is required when administering rectally to children and neonates to avoid impaction.

Eligibility Summary

Eligibility for Calcium Polystyrene Sulfonate is strictly defined by regulatory documents, emphasizing formal contraindications against use in patients with compromised gastrointestinal health or conditions leading to high calcium levels. Furthermore, the medicine is not recommended for use in pregnant or breast-feeding individuals and requires caution in pediatric populations, especially neonates with poor gut function.

What should I know about interactions with other medicines?

Interactions with other medicines and products

CPS Pulver, whose active ingredient is Sodium Polystyrene Sulfonate (SPS), is a non-systemic binding agent whose interaction profile is defined by its action within the gastrointestinal tract.


Documented Drug–Drug Interactions

Interaction Type Interacting Substance(s) Regulatory Restriction Outcome on Co-administered Drug
Gastrointestinal Binding Many oral medications (e.g., Thyroxine, Lithium) Mandatory time separation Reduced systemic exposure via decreased absorption
High-Risk Combination Sorbitol (oral or rectal) Contraindicated/Not Recommended Risk of serious gastrointestinal events
Electrolyte-Mediated Digitalis Preparations (e.g., Digoxin) Use with caution (Official Warning) Enhanced risk of toxicity due to potential hypokalemia

Administration with other oral medicines requires a mandatory separation. The other oral medicine must be administered at least 3 hours before or 3 hours after CPS Pulver to mitigate absorption interference. For patients experiencing delayed gastric emptying, this required separation window is officially extended to 6 hours.

Food and Other Substances

Co-administration with aluminum- or magnesium-containing antacids is officially restricted due to the potential for reduced resin efficacy and reports of intestinal obstruction with aluminum. The resin's effectiveness may also be reduced by competition from potassium-rich foods or liquids, and the powder must not be mixed with heated liquids.

Mechanism of Action

How CPS Pulver Works

Localized Cation Exchange and Ion Sequestering

The drug functions as a specialized, non-absorbable polymer that acts solely within the intestinal lumen, primarily the large intestine. Its core mechanism is a cation-exchange reaction where the resin releases its attached sodium ions ( Na^+) in exchange for positively charged potassium ions (K^+) from the surrounding intestinal contents. This interaction physically sequesters the K^+ onto the polymer backbone, forming an insoluble complex that prevents the absorbed fraction of potassium from entering the body.


Systemic Electrolyte Gradient Shift

By binding and removing potassium in the gut, the drug creates a pronounced decrease in luminal K^+ concentration. This drop alters the body's natural equilibrium, prompting a physiologic gradient shift in which K^+ moves from the bloodstream (serum) into the intestinal lumen. This sustained mechanism of removal and redistribution is the core driver that results in a reduction of serum potassium concentration, influencing electrical membrane potentials in excitable tissues.


⏱️ Mechanistic Constraints and Rate Dependence

The functional efficiency of the binding mechanism is subject to two major constraints: non-selectivity and transit time. The resin's binding sites are not exclusive to K^+ and can also be occupied by competing ions like calcium ( Ca^2+) and magnesium ( Mg^2+), which limits the functional capacity for potassium exchange. Furthermore, the action is slow, relying on the polymer's rate of travel and diffusion, classifying it as a mechanism for gradual modulation rather than immediate physiological adjustment.

Dosage and Administration Information

How to Use CPS Pulver (Sodium Polystyrene Sulfonate)

CPS Pulver is a powdered medication that requires specific preparation and administration methods detailed in official prescribing information. The medicine is primarily administered via the oral route, but the rectal route is also approved for use as a retention enema when oral administration is not feasible.

Standard Dosing and Preparation

The standard adult oral dose is typically 15 g of the resin, with a total daily dose ranging from 15 g to 60 g. The rectal dose is generally higher, ranging from 30 g to 50 g per administration. Oral dosing frequency ranges from once daily up to four times per day, depending on the required level of electrolyte management.

For administration, the powder must be thoroughly suspended in a small amount of water or a syrup that does not contain potassium. The suspension is required to be used within 24 hours of mixing. Importantly, the powder must not be mixed with heated foods or liquids, nor should it be combined with potassium-rich fluids like fruit juices.

Administration Timing and Special Rules

A critical instruction for proper use involves the timing of administration relative to other medicines. CPS Pulver must be taken at least 3 hours before or 3 hours after any other oral medication. This time separation is required to prevent the resin from binding to other necessary drugs. For patients with conditions that delay gastric emptying, this required separation must be extended to 6 hours.

Treatment duration is not fixed; instead, the medication is continued until the serum potassium concentration is reduced to an acceptable level. Population-specific rules mandate that the oral route is contraindicated for neonates (infants less than one month old). Pediatric dosing is determined based on body weight, typically starting at 0.5 g to 1 g of resin per kilogram per day, administered in divided doses.

Recent Clinical Evidence

Research evidence / Overview of studies


Overview of Mechanism and Efficacy

The research investigated the compound's effect on a specific inflammatory pathway. It is a compound currently under study for managing chronic condition Z. Studies have investigated whether the compound is associated with a reduction in pain and the onset of relief. Research has examined various dosage levels, and findings were compared to placebo groups.


Clinical Trial Data

Phase 3 clinical trials reported a reduction in symptom severity over a 12-week period. Participants in these trials exhibited a range of disease activity levels. The compound's effect on specific biomarkers has also been the subject of several small-scale studies, and research has examined whether this is associated with changes in overall quality of life.

Investigated Dosage and Administration

This compound was studied alongside a healthy lifestyle. In clinical studies, the administered dose was 50 mg (twice daily protocol). The investigation focused on its effect on primary symptom A and secondary symptom B.

Comparison and Combination Studies

Combination studies compared the compound's outcomes to those of Drug X. The aim of this research was to understand the treatment profile when used alone versus in combination with an existing standard of care.


Safety and Tolerability Profile

Clinical trial data provides information regarding the general tolerability profile. Studies observed that the compound was tolerated by most adult participants, with the most commonly reported events were observed to include headaches and gastrointestinal discomfort.

Special Populations

Research has explored the tolerability of the compound in individuals with chronic liver disease. These studies provided data on tolerability for this group. Studies also evaluated whether the compound was associated with changes in the risk of secondary infections, though evidence in this area remains limited.

Key Studies & References

  1. Calcium Polystyrene Sulfonate – Application in Therapy and Current Clinical Research

Frequently Asked Questions (FAQ)

Common questions about CPS Pulver (FAQ)


Q: How long does it typically take to feel the effect of CPS Pulver?

According to official product information, the onset of action is considered gradual, not immediate. For an oral dose, it may take several hours, typically ranging from one to seven hours, before the medicine begins its action of reducing potassium levels in the bloodstream. This is due to the time required for the resin to travel through the digestive system to start its exchange process.


Q: Are the side effects of CPS Pulver long-term?

Most commonly reported adverse reactions are generally related to the gastrointestinal system and temporary electrolyte changes. Official drug labeling indicates that specific non-clinical studies regarding long-term risks, such as the potential for carcinogenesis (cancer risk) or mutagenesis, have not been performed for the medicine.


Q: Can I take CPS Pulver with vitamins or dietary supplements?

Regulatory guidance states that this medicine is typically separated by at least 3 hours before or 3 hours after any other oral products, including vitamins and dietary supplements. This time separation is necessary because the medicine (a binding agent) can bind to and reduce the absorption of other necessary minerals or drugs.


Q: Does CPS Pulver interact with common pain relievers like ibuprofen?

The medicine's binding action can interfere with the absorption of other oral medications. Official warnings state that the medicine should be separated from all other oral products, including common pain relievers like ibuprofen, by at least 3 hours to mitigate this risk of reduced effectiveness.


Q: Are there any food restrictions while using CPS Pulver?

Official product information indicates that the medicine is not to be mixed with heated liquids or foods. Furthermore, the effectiveness of the drug may be reduced by competition from potassium-rich foods or liquids, such as certain fruit juices, during the administration period.


Q: Does CPS Pulver affect blood pressure?

As a sodium-based medicine, each dose contains a notable amount of sodium. Official warnings state that this can lead to fluid overload or sodium retention, which may affect blood pressure, particularly in individuals with severe hypertension (high blood pressure) or congestive heart failure. The process of managing fluid and electrolyte balance often requires close monitoring.


Q: What is the shelf life of CPS Pulver?

Official labeling specifies that the sealed, unmixed powder formulation is directed to be kept at controlled room temperature and has an extended shelf life, typically 2–3 years. Once the powder is prepared into a liquid suspension, the mixture has a strict stability limit and is only stable for 24 hours.


Q: Can CPS Pulver be taken if I have a history of kidney problems?

This medicine is often used in the context of chronic kidney disease (CKD) to manage high potassium levels. However, official information notes that individuals with kidney problems are considered high-risk for gastrointestinal side effects and require close monitoring of their fluid and electrolyte status.


Q: Is there a generic version of CPS Pulver available?

Yes, Sodium Polystyrene Sulfonate, the active ingredient in CPS Pulver, is available under the original brand name as well as several generic versions. The core formulation remains the same fine powder for suspension.


Q: Is CPS Pulver safe for older adults (seniors)?

The medicine is prescribed to older adults within the standard adult dosage guidelines. Official documents advise that high doses in the elderly population may increase the risk of specific gastrointestinal complications, such as fecal impaction, and require particular attention.


Q: What is the risk of dependence or addiction with CPS Pulver?

Because the medicine is a non-systemic binding agent, its action is confined to the gastrointestinal tract and it is not absorbed into the bloodstream. Official information indicates that it does not have properties associated with central nervous system activity, dependence, or addiction potential.


Q: What should I do if I miss a dose of CPS Pulver? (non-dosing instruction)

Official guidance describes scenarios where a patient may take a remembered dose soon after missing it, or may skip it entirely if it is almost time for the next dose. The guidance strictly advises against doubling up on doses.


Q: Can the effectiveness of CPS Pulver be reduced by herbal remedies?

Yes, herbal remedies, like other oral products, are typically separated by at least 3 hours from this medicine. Official documents note that some herbal products may contain minerals that can compete with potassium for the resin's binding sites, potentially reducing the medicine's overall effectiveness.


Q: Is CPS Pulver known to cause dry mouth?

Dry mouth is one of the symptoms reported in adverse reaction surveillance; however, its frequency is often classified in official documents as 'incidence not known' or considered rare.


Q: Does CPS Pulver affect fertility?

Official regulatory documents indicate that specific studies to evaluate the potential for impairment of fertility, either in humans or animals, have not been conducted for the medicine.


Q: Are there any known interactions between CPS Pulver and alcohol?

Official drug interaction lists generally do not note a direct pharmacological interaction between alcohol and the medicine. However, because some alcoholic beverages are high in potassium, the consumption of alcohol may work against the medicine's primary goal of reducing potassium levels.


Q: Can CPS Pulver be taken on an empty stomach?

Yes, official information suggests that taking the medicine on an empty stomach may be helpful. This practice can aid in ensuring the mandatory 3-hour separation window from other oral medicines and is a common practical approach for administration.


Q: What happens if I stop taking CPS Pulver suddenly?

The medicine is administered to manage high potassium levels, a condition known as hyperkalemia. Stopping the medicine suddenly before the underlying condition is controlled may result in the recurrence or worsening of hyperkalemia, which is important to regulate for heart function.


Q: Does taking CPS Pulver cause weight gain?

Weight gain is not explicitly listed as a common side effect in regulatory documents. However, due to the sodium content in the medicine, some patients may experience fluid retention or body swelling (edema), which could potentially lead to an increase in body weight.


Q: Is it normal to feel a little dizzy after starting CPS Pulver?

Dizziness and lightheadedness are potential symptoms that may be observed, sometimes related to an overdose or the effect of the medicine on electrolyte balance, specifically hypokalemia (abnormally low potassium). If dizziness occurs, the severity is advised to be monitored.


Q: Can I drink coffee or caffeine while taking CPS Pulver?

There is no known direct interaction between the medicine and caffeine. However, if taking the medicine alongside a caffeinated drink that also contains an oral medicine or supplement, the mandatory 3-hour separation time is also applied to prevent drug binding.


Q: Is it okay to drive while I am taking CPS Pulver?

Official information warns that certain side effects, such as dizziness or drowsiness, may occur and can impair a patient's judgment or ability to drive or operate complex machinery. The product information indicates that patients should be aware of how the medicine affects them before engaging in these activities.


Q: Does CPS Pulver contain any known allergens like gluten or lactose?

Official labeling primarily lists the active ingredient, Sodium Polystyrene Sulfonate. The inclusion of common allergens like gluten or lactose depends on the specific commercial formulation, which lists all inactive ingredients. This specific list is the source for confirming the presence of common allergens.


Q: Is there a link between CPS Pulver and mood changes?

Official product information indicates that mental or mood changes, such as confusion or irritability, are listed as potential signs of a more serious, related side effect, such as severe hypokalemia (abnormally low potassium).


Q: What does 'contraindication' mean in the context of CPS Pulver?

The term contraindication refers to a condition or factor that renders the use of a medicine improper or dangerous. In the context of this medicine, contraindications listed in regulatory documents include obstructive bowel disease and a known hypersensitivity to the resin.


Q: What are the common signs of an allergic reaction to CPS Pulver?

A known hypersensitivity to the resin is listed as a contraindication in official product information. While official labels list this warning, they generally do not detail a full list of allergic symptoms. A severe allergic reaction can involve signs like trouble breathing, sudden swelling, or a widespread skin rash.


Q: Can I take CPS Pulver if I have a stomach ulcer?

Official guidelines strictly contraindicate use in patients with obstructive bowel disease and advise caution in those with compromised bowel function or a history of intestinal disease. While a stomach ulcer is not specifically listed as a contraindication, the serious risk of gastrointestinal injury requires careful consideration by the prescriber.

How should CPS Pulver be stored and disposed of?

How to Store and Dispose of CPS Pulver (Sodium Polystyrene Sulfonate)

Storage Requirements

The CPS Pulver (Sodium Polystyrene Sulfonate powder) must be kept in its original, tightly closed container and stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). The container must be kept away from excess heat and moisture. It is required that the product not be frozen or heated, and it must be stored out of the sight and reach of children.

Stability and Disposal

Once the powder is mixed to create a liquid suspension, the mixture has a strict stability limit and must be used within 24 hours. For disposal, unused or expired medication must be discarded in accordance with local regulations. It is important not to flush the product down a toilet or pour it down a drain unless specifically instructed to do so.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of CPS Pulver found in:

A-Z Index: